Astrana Health, Inc.
Astrana Health, Inc.（ASTH）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ASTH · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Astrana Health, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ASTH 季度内部人买卖趋势
ASTH 内幕交易卖出 · ASTH 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ASTH CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ASTH 高管卖出股份 · ASTH 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 16, 2026 | Basho Chandan COO and CFO | Other | 8,155 | $312K | Form 4 |
| Apr 14, 2026 | Basho Chandan COO and CFO | Other | 3,870 | $113K | Form 4 |
| Apr 6, 2026 | Lam Thomas S. Director | Award | 41,667 | — | Form 4 |
| Apr 6, 2026 | Sim Kenneth T. Executive Chairman · Director | Award | 100,000 | — | Form 4 |
| Apr 6, 2026 | Sim Brandon CEO and President | Award | 201,056 | — | Form 4 |
| Apr 1, 2026 | Kumar Dinesh M. Chief Medical Officer | Award | 35,300 | — | Form 4 |
| Apr 1, 2026 | Kumar Dinesh M. Chief Medical Officer | Other | 57,980 | $1.42M⚡ | Form 4 |
| Apr 2, 2026 | Basho Chandan COO and CFO | Other | 2,092 | $52K | Form 4 |
| Mar 26, 2026 | Sobotka Glenn CAO | Other | 662 | $16K | Form 4 |
| Mar 5, 2026 | Lam Thomas S. Director | Other | 9,266 | $232K | Form 4 |
| Mar 5, 2026 | Kumar Dinesh M. Chief Medical Officer | Other | 1,697 | $43K | Form 4 |
| Mar 5, 2026 | Basho Chandan COO and CFO | Other | 1,240 | $31K | Form 4 |
| Feb 2, 2026 | Sim Brandon CEO and President | Option | 21,334 | $496K | Form 4 |
| Jan 23, 2026 | Kumar Dinesh M. Chief Medical Officer | Other | 10,759 | $292K | Form 4 |
| Jan 13, 2026 | Schmidt David Director | Option | 20,000 | $116K | Form 4 |
| Jan 13, 2026 | Schmidt David Director | Other | 4,269 | $116K | Form 4 |
| Jan 1, 2026 | Kumar Dinesh M. Chief Medical Officer | Other | 5,102 | $127K | Form 4 |
| Dec 8, 2025 | Lam Thomas S. Director | Option | 29,502 | $525K | Form 4 |
| Dec 8, 2025 | Lam Thomas S. Director | Other | 25,866 | $569K | Form 4 |
| Nov 10, 2025 | Sim Kenneth T. Executive Chairman · Director | Option | 29,502 | $525K | Form 4 |
| Nov 7, 2025 | Kitayama Mitchell W Director | Option | 12,000 | $218K | Form 4 |
| Nov 10, 2025 | Mazdyasni Matthew Director | Option | 20,000 | $364K | Form 4 |
| Nov 3, 2025 | Marsh Linda Director | Option | 20,000 | $364K | Form 4 |
| Nov 3, 2025 | Marsh Linda Director | Other | 11,033 | $364K | Form 4 |
| Oct 2, 2025 | Basho Chandan COO and CFO | Other | 1,979 | $55K | Form 4 |
Sim Kenneth T.
Executive Chairman · Director
日期
Nov 10
股数
29,502
均价
$17.78
总金额
$525K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ASTH 内幕交易
ASTH 内幕交易
Astrana Health, Inc.（ASTH）内幕交易数据来源于公司内部人（包括Kumar Dinesh M. (Chief Medical Officer), Basho Chandan (COO and CFO), Schmidt David (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ASTH内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Astrana Health, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ASTH 内幕交易 · 5个问题Astrana Health, Inc.（ASTH）的内部人包括高管和董事，如Kumar Dinesh M. (Chief Medical Officer), Basho Chandan (COO and CFO), Schmidt David (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026